Oral contraceptive/DehydroepiandrosteroneAlternative Names: OC+DHEA; OC-DHEA
Latest Information Update: 22 Mar 2010
At a glance
- Originator Bayer Schering Pharma
- Class Androstenols; Hormonal replacements; Small molecules; Testosterone congeners
- Mechanism of Action Estrogen receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Decreased libido